The following people constitute the Editorial Board of Academic Editors for PeerJ. These active academics are the Editors who seek peer reviewers, evaluate their responses, and make editorial decisions on each submission to the journal. Learn more about becoming an Editor.
Professor for Biochemistry with Focus on electron Cryo Microscopy at the Julius Maximilians University Würzburg
Tom Bourne is visiting Professor at KU Leuven Belgium and Imperial College London. He is a consultant gynaecologist at Queen Charlotte’s and Chelsea Hospital, Imperial College NHS Trust, London. He has published over 230 papers in international journals. His current research relates to diagnostics in gynaecology, early pregnancy complications, embryonic growth, and the diagnosis of ovarian and endometrial cancer. His H-index is 45
Professor of Pulmonary Medicine at the Univeristy of Montpellier. Former Director of the INSERM Laboratory for the Immunopathology of Asthma & former chairman of the Global Initiative for Asthma (GINA). Founder & Chairman of ARIA (Allergic Rhinitis & its Impact on Asthma). Chairman of the WHO Global Alliance against Chronic Respiratory Diseases (GARD). Former President of the Societé Française dAllergologie et dImmunologie Clinique. Former EiC of the journal Allergy.
Senior Lecturer for the Department of Medical Virology, blood borne virus division, at the University of Pretoria and Senior Medical Scientist for the National Health Laboratory System, Tshwane Academic Division. Responsibilities involve teaching and training, research and the provision of a viral diagnostic service to the public and private sector.
Senior Research Fellow in the School of Psychology and Speech Pathology, Curtin University. Research Associate in the Centre for Evidence-Based Intervention, University of Oxford.
Interests span health, developmental, and clinical psychology, with the overarching aim of understanding how both individual difference and social/community variables are related to psychological, social, and educational outcomes across the life-span. I am particularly interested in individual differences in cognitive and self-regulatory processes (such as appraisal, coping, and emotion regulation) and their potential links with emotional vulnerability. I am a Research Associate in the Centre for Evidence-Based Intervention, University of Oxford, where I have an ongoing collaboration with Dr Lucie Cluver on projects examining the impacts of familial HIV/AIDS on psychosocial outcomes for South African children.
Laura Boykin is a Research Fellow at The University of Western Australia. She is interested in using genomic data to answer real-world problems. Specifically she is interested in invasive species, particularly Bemisia tabaci (whiteflies). Other areas of interest are: comparative genomics, phylogenetic analyses (of DNA sequences) and also high performance computing. Combining all of the above to help smallholder famers in Africa is her ultimate goal. She was recently named a TED 2015 and presented her work on cassava whitefly at TED in Vancouver.
Research Entomologist and Curator of Hymenoptera, National Museum of Natural History, Smithsonian Institution. Research interests: Phylogenomics, systematics, evolution, biogeography, and comparative genomics of aculeate Hymenoptera (bees, ants, stinging wasps); phylogenetic methodology; social insect biology; evolution of pollinators.
Erika Braga has a BA in Biology and a Ph.D in Parasitology from Federal University of Minas Gerais (UFMG), Brazil, where she is a Professor of Parasitology. Coordinator of Parasitology Post-graduate Program (UFMG). Head of Malaria Laboratory at UFMG. Her research is focused on two distinct approaches: study of immune response in human malaria and study of avian malaria in wild birds. Academic Editor of PLOS ONE.
Vania Braga's research interests include understanding the signalling pathways required for epithelial specification and how these processes are subverted during diseases and tumour progression. She is Deputy-Head of the Molecular Medicine Section, and was appointed Campus Director for the Faculty of Medicine (2012-2015). Dr. Braga participates in a number of editorial boards, review panels and grant committees in Europe.
Inserm Researcher in the field of Cardiovascular Research, currently focusing on therapeutic angiogenesis with polymer-based targeted growth factor delivery.
PhD in Tumor Biology (Pr Yihai Cao, Karolinska Institutet, Sweden), and expertise in Adipose tissue angiogenesis. Postdoc at UCLA (Pr Lily Wu) in molecular imaging and tumor lymphangiogenesis field.
Member of European Vascular Biology Organisation, French society for Cardiovascular Research, French society for Angiogenesis Research.
Paolo Brambilla is medical doctor, specialist in psychiatry, PhD in neuroscience. He has been research fellow at the University of Pittsburgh and at the University of Texas at San Antonio and adjunct Assist. Prof. of Psychiatry at the University of North Carolina. Since 2004 Dr. Brambilla is Assistant Professor of Psychiatry at the University of Udine, Italy. He co-authored more than 140 scientific peer-reviewed papers. His current lifetime h-index is 35.
Dr Vincenzo Brancaleone is Assistant Professor of Pharmacology, Dept. of Science, University of Basilicata.
He performs reviewer activity for international relevant and impacted scientific journal: Mediators of Inflammation (IF:3.263), British Journal of Pharmacology (IF:4.409), Inflammation Research (IF:2.109), Diabetes & Vascular Disease Research (IF:2.116), FasebJ (IF:5.299)
Dr. Brancaleone main research field includes: 1) vascular biology in vivo and in vitro in physiopathological conditions related to gaseous mediators: role of nitric oxide (NO) and hydrogen sulfide (H2S); 2) role of sphingosine-1-kinase/sphingosine-1-phosphate (S1PK/S1P) pathway in vascular, respiratory and inflammatory processes;
3) role of Annexin A1 and its receptor (Formylated Peptide Receptor 2, FPR2) in resolving mechanism in inflammation.
Dr. Brancaleone is full member of British Pharmacological Society (BPS) and Italian Society of Pharmacology (SIF).